Literature DB >> 7069226

Toxic-shock syndrome in Minnesota: results of an active-passive surveillance system.

M T Osterholm, J C Forfang.   

Abstract

In January 1980, the Minnesota Department of Health began a surveillance system for toxic-shock syndrome (TSS) with both epidemiologically defined active and passive components. As of June 30, 1981, 197 confirmed cases of TSS, 15% of all nationally reported cases, have been in Minnesota residents. The onset in 61 of the cases was before 1980; these cases were retrospectively recognized and reported. Of the 136 cases reported between January 1980 and June 1981, 114 (83.8%) cases were tampon-associated. During the 18 months of active surveillance, there was no difference (P greater than 0.2) in the quarterly distribution of total or tampon-associated TSS cases. The onset of illness in 55 tampon-associated cases was during the nine months of surveillance in which Rely tampons (Procter and Gamble, Cincinnati, Ohio) were on the market, whereas the onset in 59 tampon-associated cases was during the nine months following their removal from the market.

Entities:  

Mesh:

Year:  1982        PMID: 7069226     DOI: 10.1093/infdis/145.4.458

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Toxic shock syndrome: chronology of state and federal epidemiologic studies and regulatory decision-making.

Authors:  M E Donawa; G R Schmid; M T Osterholm
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

Review 3.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group.

Authors:  B A Perkins; J M Flood; R Danila; R C Holman; A L Reingold; L A Klug; M Virata; P R Cieslak; S R Zaki; R W Pinner; R F Khabbaz
Journal:  Emerg Infect Dis       Date:  1996 Jan-Mar       Impact factor: 6.883

Review 5.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

6.  Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics.

Authors:  Aaron S DeVries; Lindsey Lesher; Patrick M Schlievert; Tyson Rogers; Lourdes G Villaume; Richard Danila; Ruth Lynfield
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

7.  Evaluation of surveillance methods for staphylococcal toxic shock syndrome.

Authors:  Lindsey Lesher; Aaron Devries; Richard Danila; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

Review 8.  Staphylococcal superantigens in colonization and disease.

Authors:  Stacey X Xu; John K McCormick
Journal:  Front Cell Infect Microbiol       Date:  2012-04-17       Impact factor: 5.293

9.  Syndromic surveillance.

Authors:  Zygmunt F Dembek; Dennis G Cochrane; Julie A Pavlin
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

10.  Lyme disease in Minnesota: epidemiologic and serologic findings.

Authors:  M T Osterholm; J C Forfang; K E White; J N Kuritsky
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.